164 related articles for article (PubMed ID: 33422975)
1. The effect of medications associated with drug-induced pancreatitis on pancreatic cancer risk: A nested case-control study of routine Scottish data.
McDowell RD; Hughes CM; Murchie P; Cardwell CR
Cancer Epidemiol; 2021 Apr; 71(Pt A):101880. PubMed ID: 33422975
[TBL] [Abstract][Full Text] [Related]
2. A systematic assessment of the association between frequently prescribed medicines and the risk of common cancers: a series of nested case-control studies.
McDowell RD; Hughes C; Murchie P; Cardwell C
BMC Med; 2021 Jan; 19(1):22. PubMed ID: 33494748
[TBL] [Abstract][Full Text] [Related]
3. Exposure to Ranitidine and Risk of Bladder Cancer: A Nested Case-Control Study.
Cardwell CR; McDowell RD; Hughes CM; Hicks B; Murchie P
Am J Gastroenterol; 2021 Aug; 116(8):1612-1619. PubMed ID: 34028367
[TBL] [Abstract][Full Text] [Related]
4. The effect of medications which cause inflammation of the gastro-oesophageal tract on cancer risk: a nested case-control study of routine Scottish data.
Busby J; Murchie P; Murray L; Iversen L; Lee AJ; Spence A; Watson MC; Cardwell CR
Int J Cancer; 2017 Apr; 140(8):1828-1835. PubMed ID: 28120338
[TBL] [Abstract][Full Text] [Related]
5. Assessing the effects of beta-blockers on pancreatic cancer risk: A nested case-control study.
Saad A; Goldstein J; Margalit O; Shacham-Shmueli E; Lawrence YR; Yang YX; Reiss KA; Golan T; Mamtani R; Halpern N; Aderka D; Mouallem M; Goldstein A; Giantonio B; Boursi B
Pharmacoepidemiol Drug Saf; 2020 May; 29(5):599-604. PubMed ID: 32196836
[TBL] [Abstract][Full Text] [Related]
6. Incretin-based pharmacotherapy and risk of adverse pancreatic events in the ethnic Chinese with diabetes mellitus: A population-based study in Taiwan.
Tseng CM; Liao WC; Chang CY; Lee CT; Tseng CH; Hsu YC; Lin JT
Pancreatology; 2017; 17(1):76-82. PubMed ID: 27743712
[TBL] [Abstract][Full Text] [Related]
7. Acute Pancreatitis and Pancreatic Cancer Risk: A Nationwide Matched-Cohort Study in Denmark.
Kirkegård J; Cronin-Fenton D; Heide-Jørgensen U; Mortensen FV
Gastroenterology; 2018 May; 154(6):1729-1736. PubMed ID: 29432727
[TBL] [Abstract][Full Text] [Related]
8. Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case-control study.
Bradley MC; Hughes CM; Cantwell MM; Napolitano G; Murray LJ
Br J Cancer; 2010 Apr; 102(9):1415-21. PubMed ID: 20372155
[TBL] [Abstract][Full Text] [Related]
9. Medications that relax the lower oesophageal sphincter and risk of oesophageal cancer: An analysis of two independent population-based databases.
Spence AD; Busby J; Murchie P; Kunzmann AT; McMenamin ÚC; Coleman HG; Johnston BT; O'Rorke MA; Murray LJ; Iversen L; Lee AJ; Cardwell CR
Int J Cancer; 2018 Jul; 143(1):22-31. PubMed ID: 29396851
[TBL] [Abstract][Full Text] [Related]
10. The role of 5α-reductase inhibitors in gastro-oesophageal cancer risk: A nested case-control study.
Busby J; Karasneh R; Murchie P; McMenamin Ú; Gadalla SM; Camargo MC; Iversen L; Lee AJ; Spence AD; Cardwell CR
Pharmacoepidemiol Drug Saf; 2020 Jan; 29(1):48-56. PubMed ID: 31713940
[TBL] [Abstract][Full Text] [Related]
11. Nationwide Trends in Pancreatitis and Pancreatic Cancer Risk Among Patients With Newly Diagnosed Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors.
Lee M; Sun J; Han M; Cho Y; Lee JY; Nam CM; Kang ES
Diabetes Care; 2019 Nov; 42(11):2057-2064. PubMed ID: 31431452
[TBL] [Abstract][Full Text] [Related]
12. Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4).
Duell EJ; Lucenteforte E; Olson SH; Bracci PM; Li D; Risch HA; Silverman DT; Ji BT; Gallinger S; Holly EA; Fontham EH; Maisonneuve P; Bueno-de-Mesquita HB; Ghadirian P; Kurtz RC; Ludwig E; Yu H; Lowenfels AB; Seminara D; Petersen GM; La Vecchia C; Boffetta P
Ann Oncol; 2012 Nov; 23(11):2964-2970. PubMed ID: 22767586
[TBL] [Abstract][Full Text] [Related]
13. Total Serum Cholesterol and Pancreatic Cancer: A Nested Case-Control Study.
Chen WC; Boursi B; Mamtani R; Yang YX
Cancer Epidemiol Biomarkers Prev; 2019 Feb; 28(2):363-369. PubMed ID: 30333217
[TBL] [Abstract][Full Text] [Related]
14. Methods for the early detection of drug-induced pancreatitis: a systematic review of the literature.
Wolfe D; Kanji S; Yazdi F; Skidmore B; Moher D; Hutton B
BMJ Open; 2019 Nov; 9(11):e027451. PubMed ID: 31694842
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic Cancer Following Acute Pancreatitis: A Population-based Matched Cohort Study.
Sadr-Azodi O; Oskarsson V; Discacciati A; Videhult P; Askling J; Ekbom A
Am J Gastroenterol; 2018 Nov; 113(11):1711-1719. PubMed ID: 30315287
[TBL] [Abstract][Full Text] [Related]
16. Use of proton pump inhibitors and risk of pancreatic cancer.
Hicks B; Friis S; Pottegård A
Pharmacoepidemiol Drug Saf; 2018 Aug; 27(8):926-930. PubMed ID: 29923251
[TBL] [Abstract][Full Text] [Related]
17. Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.
Duell EJ; Casella DP; Burk RD; Kelsey KT; Holly EA
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):726-31. PubMed ID: 16614115
[TBL] [Abstract][Full Text] [Related]
18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
19. Association of oral glucocorticoid use with an increased risk of acute pancreatitis: a population-based nested case-control study.
Sadr-Azodi O; Mattsson F; Bexlius TS; Lindblad M; Lagergren J; Ljung R
JAMA Intern Med; 2013 Mar; 173(6):444-9. PubMed ID: 23440105
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
